Evaluation of minimal residual disease by flowcytometry and its clinicopathological correlation in B-lineage acute lymphoblastic leukemia in a tertiary care centre

Documenti analoghi

• Evaluation of minimal residual disease by flowcytometry and its clinicopathological correlation in B-lineage acute lymphoblastic leukemia in a tertiary care centre
  di: Himanshu Dhanda, et al.
  Pubblicazione: (2022-01-01)
• Combinatory Flowcytometric Approach in Pediatric Acute Lymphoid Leukemia Identifies Surrogate Minimal Residual Disease Markers
  di: Noreen Grace George, et al.
  Pubblicazione: (2025-03-01)
• Case series of unusual causes of transfusion requirement in pediatric age group
  di: Himanshu Dhanda, et al.
  Pubblicazione: (2022-01-01)
• A diagnostic randomized controlled trial to validate novel dried blood spot (DBS) based technology for prognosis and screening of leukemia transcripts: study protocol
  di: Saurabh Sharma, et al.
  Pubblicazione: (2026-04-01)
• Recent advances and future directions in etiopathogenesis and mechanisms of reactive oxygen species in cancer treatment
  di: Priyanka Verma, et al.
  Pubblicazione: (2023-10-01)